Sage Therapeutics, Inc.
Neuroactive steroids, compositions, and uses thereof

Last updated:

Abstract:

Described herein are steroids of Formula (I): ##STR00001## and pharmaceutically acceptable salts thereof; wherein R.sup.1, R.sup.2a, R.sup.2b, R.sup.3, R.sup.4, R.sup.5a, R.sup.5b, R.sup.6 and Z are as defined herein. Such compounds are contemplated useful for the prevention and treatment of a variety of CNS-related conditions, for example, treatment of sleep disorders, mood disorders, schizophrenia spectrum disorders, convulsive disorders, disorders of memory and/or cognition, movement disorders, personality disorders, autism spectrum disorders, pain, traumatic brain injury, vascular diseases, substance abuse disorders and/or withdrawal syndromes, and tinnitus.

Status:
Grant
Type:

Utility

Filling date:

9 Jul 2020

Issue date:

19 Oct 2021